A double-blind, randomized, placebo-controlled study of early oseltamivir treatment of influenza in children 1-3 years of age

Trial Profile

A double-blind, randomized, placebo-controlled study of early oseltamivir treatment of influenza in children 1-3 years of age

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Apr 2014

At a glance

  • Drugs Oseltamivir (Primary)
  • Indications Influenza virus infections; Otitis media
  • Focus Therapeutic Use
  • Acronyms ETOPOM
  • Most Recent Events

    • 03 Sep 2010 Results published in Clinical Infectious Diseases.
    • 04 Jul 2009 Actual end date (June 2009) added as reported by ClinicalTrials.gov.
    • 24 Jun 2009 Actual patient number (409) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top